Skip to main content
logo
Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.330
+0.050 (3.91%)
At close: Jun 22, 2026, 4:00 PM EDT
1.350
+0.020 (1.50%)
After-hours: Jun 22, 2026, 7:47 PM EDT

Enveric Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
---2.2917.7217.36
Cash & Short-Term Investments
---2.2917.7217.36
Cash Growth
----87.09%2.12%999.55%
Other Current Assets
0.470.260.491.290.710.38
Total Current Assets
5.384.942.733.5818.4317.74
Net Property, Plant & Equipment
0.120.160.310.510.740.47
Other Intangible Assets
--0.040.210.386.92
Goodwill
-----1.59
Other Long-Term Assets
0.03-----
Total Assets
5.525.13.084.319.5526.72
Accounts Payable
0.280.580.521.220.460.68
Accrued Expenses
0.180.240.741.081.711.29
Current Portion of Leases
----0.060.11
Other Current Liabilities
-0.10.230.051.760.65
Total Current Liabilities
0.460.921.492.3442.74
Long-Term Leases
-----0.07
Other Long-Term Liabilities
-----1.61
Total Long-Term Liabilities
-----1.68
Total Liabilities
0.460.921.492.3444.41
Common Stock
0.020.01000.020.01
Additional Paid-in Capital
---99.0294.483.07
Accumulated Other Comprehensive Income
----0.57-0.54-0.03
Retained Earnings
-116.48-114.85-106.08-96.5-79.21-60.74
Total Common Shareholders' Equity
-116.46-114.84-106.071.9614.6722.31
Minority Interest
----0.89-
Shareholders' Equity
-116.46-114.84-106.071.9615.5622.31
Total Liabilities & Equity
5.525.13.084.319.5526.72
Total Debt
-0000.060.18
Net Cash (Debt)
--0-02.2917.6617.18
Net Cash Growth
----87.04%2.80%988.38%
Net Cash Per Share
---190.762198.346546.82
Book Value
-116.46-114.84-106.071.9614.6722.31
Book Value Per Share
-172.56-343.08-2531.11163.111826.378500.31
Tangible Book Value
-116.46-114.84-106.121.7514.2913.79
Tangible Book Value Per Share
-172.56-343.08-2532.12145.521779.115256.73
SEC Filings: 10-K · 10-Q